Congenital syphilitic skeletal manifestations in a premature infant revisited.
Increasing rates of congenital syphilis have been reported in recent years despite the availability of adequate therapy. In our perinatal-neonatal center, approximately 1.5% of newborns have reactive serologic tests for syphilis. Untreated or partly treated maternal syphilis can adversely affect neonatal outcome since the treponeme can cross the placenta at any time during pregnancy. As a result of hematogenous placental transmission, neonatal manifestations are usually systemic and similar to the secondary stage of syphilis, and include hepatosplenomegaly, jaundice, neurosyphilis, and skeletal changes. A case of early congenital syphilis in an extremely premature infant with primary skeletal involvement is presented.
Ilagan
N B
NB
Weyhing
B
B
Liang
K C
KC
Womack
S J
SJ
Shankaran
S
S
D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000000981:diagnostic imaging* / Q000188:drug therapy; D008297:Male; D010406:Penicillins / Q000627:therapeutic use; D011859:Radiography; D013590:Syphilis, Congenital / Q000000981:diagnostic imaging* / Q000188:drug therapy; D013977:Tibia / Q000000981:diagnostic imaging*
D005839:Gentamicins; D010406:Penicillins